Aromatase inhibitors: all 608 studies that test it
Page 6 of 7. Open to participants first (88), then studies with results posted, then the rest; newest registration first within each.
- An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial AcneCompletedNCT00725439Phase 2
- An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type PsoriasisCompletedNCT00725348Phase 2
- Study on Anti-inflammatory Effects of Topical R115866 GelCompletedNCT00719121Phase 1
- Regulation of Cortisol Metabolism and Fat PatterningStatus unknownNCT00694733Not applicable
- Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor TherapyStatus unknownNCT00688194Phase 3
- Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerStatus unknownNCT00687648Phase 2
- Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 MutationCompletedNCT00673335Phase 3
- Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryTerminatedNCT00651976Early Phase 1
- A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerCompletedNCT00649090Phase 4
- Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mgCompletedNCT00648154Phase 1
- Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mgCompletedNCT00648063Phase 1
- Gynecomastia Extension StudyCompletedNCT00637182Phase 3
- Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT00634894Phase 2
- Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast CancerCompletedNCT00629616Phase 2
- Letrozole vs. Clomiphene Citrate in Patients With Anovulatory InfertilityCompletedNCT00610077Phase 3
- Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast CancerCompletedNCT00588003Phase 1
- Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in WomenCompletedNCT00565240Not applicable
- A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast CancerCompletedNCT00544986Phase 4
- Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By SurgeryStatus unknownNCT00541086Phase 3
- Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate MarkersCompletedNCT00535418Phase 2/3
- Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCCompletedNCT00532272Phase 2
- Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast CancerTerminatedNCT00516542Phase 1
- Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast CancerTerminatedNCT00498901Phase 2
- Letrozole Versus Clomifene Citrate for Ovulation InductionCompletedNCT00478504Phase 4
- Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy VolunteersCompletedNCT00467493Phase 2
- Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic SyndromeTerminatedNCT00438321Phase 1
- Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast CancerCompletedNCT00437853Not applicable
- Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast CancerTerminatedNCT00437359Phase 2
- Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 3
- Insulin Sensitivity in Men With the Metabolic SyndromeSuspendedNCT00433173Not applicable
- HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.Active, not recruitingNCT00412022Phase 3
- Testosterone Effects on Men With the Metabolic SyndromeWithdrawnNCT00382057Phase 2
- A Study of Letrozole in the Treatment of Endometrial CancerCompletedNCT00333086Phase 2
- Letrozole in Metastatic Breast Cancer in Combination With ChemotherapyCompletedNCT00333047Phase 2/3
- Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast CancerCompletedNCT00332852Phase 3
- Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast CancerCompletedNCT00330317Phase 3
- Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast CancerCompletedNCT00329940Phase 3
- Testosterone-Driven Growth-Hormone (GH) Secretion in Aging MenCompletedNCT00309855Phase 1
- Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive PatientsCompletedNCT00309491Phase 3
- Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00305825Phase 2
- Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast CancerCompletedNCT00301457Phase 3
- 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast CancerCompletedNCT00300508Phase 3
- Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With ExemestaneCompletedNCT00291798Phase 2
- ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.CompletedNCT00291759Phase 3
- Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.CompletedNCT00287534Phase 2
- Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian EndometriosisCompletedNCT00286351Phase 4
- ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 YearsCompletedNCT00286117Phase 3
- Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar IchthyosisCompletedNCT00282724Phase 2/3
- Letrozole in Postmenopausal Women at Increased Risk for Breast CancerStatus unknownNCT00280930Phase 2
- Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast CancerCompletedNCT00279448Phase 3
- Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast CancerTerminatedNCT00267553Phase 3
- Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian CancerCompletedNCT00261027Phase 2
- Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast CancerCompletedNCT00247663Phase 2
- Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant TherapyCompletedNCT00247650Phase 2
- Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast CancerCompletedNCT00244959Phase 2
- Open Label Arimidex in GynecomastiaCompletedNCT00241436Phase 2
- Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk AssessmentTerminatedNCT00241046Phase 4
- Letrozole in the Treatment of Severe and Recurrent EndometriosisCompletedNCT00240942Phase 2
- Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast DensityCompletedNCT00238316Phase 2
- Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast CancerCompletedNCT00238290Phase 2
- Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With LetrozoleCompletedNCT00237224Phase 4
- Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast CancerCompletedNCT00237211Phase 2
- Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen TreatmentCompletedNCT00237198Phase 2
- Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal WomenCompletedNCT00237133Phase 4
- Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus ZoladexCompletedNCT00235937Phase 2
- PROACT - Pre-Operative Arimidex Compared To TamoxifenCompletedNCT00232661Phase 3
- S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerWithdrawnNCT00217659Phase 2
- Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of DiseaseCompletedNCT00200174Not applicable
- FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to LetrozoleCompletedNCT00199134Phase 2
- Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian CancerCompletedNCT00181688Phase 2
- Trilostane for Androgen-Independent Prostate CancerCompletedNCT00181597Phase 2
- Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer PatientsCompletedNCT00174343Phase 2
- Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast CancerTerminatedNCT00171847Phase 4
- Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial CancerCompletedNCT00171808Phase 2
- Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast CancerCompletedNCT00161291Phase 2
- Short-term Effects of Aromatase Inhibition in Obese MenCompletedNCT00138710Phase 3
- Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBCCompletedNCT00134680Phase 2
- Arimidex Multicenter Trial in Growth Hormone (GH) Deficient BoysCompletedNCT00133354Phase 2/3
- Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer PatientsCompletedNCT00128843Phase 2
- STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)Status unknownNCT00126360Phase 4
- Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast DensityCompletedNCT00114270Not applicable
- Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00107263Phase 3
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast CancerTerminatedNCT00101062Phase 2
- The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerTerminatedNCT00097344Phase 3
- Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast CancerCompletedNCT00084396Phase 2
- Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast CancerWithdrawnNCT00080613Phase 2
- Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast CancerCompletedNCT00078832Phase 3
- Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerCompletedNCT00066586Not applicable
- Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWithdrawnNCT00057993Phase 2
- Arimidex in McCune Albright SyndromeCompletedNCT00055302Phase 2
- Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00049062Phase 2
- Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerCompletedNCT00044291Phase 3
- Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal WomenTerminatedNCT00040014Phase 2
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00032136Phase 3
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate CancerCompletedNCT00031889Phase 2
- Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of TamoxifenCompletedNCT00016432Phase 3
- Letrozole in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00014638Phase 4
- Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast CancerTerminatedNCT00010322Phase 3
- Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast CancerCompletedNCT00010010Phase 2
- A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate CancerTerminatedNCT00006371Phase 2